Skip to main content

Table 1 The Basic Characteristics of MDR/XDR Acinetobacter baumannii patients

From: Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit

Characteristics
n (%)
  Survivors
72 (70.59)
Nonsurvivors
30 (29.41)
Odds Ratio
(95%CI)
P value
Age, mean ± SD, month   30 (9.6, 88.75) 42 (9.825, 102.75) 0.691 (−29.63, 12.02) 0.404
Male/Female (n=)   44/28 19/11 (0.286,0.478) 0.835
Underlying disorders Pneumonia n (%) 61 (84.7) 25 (83.3) 0.902 (0.284,2.862) 0.862
Meningitis n (%) 1 (1.38) 6 (20) 17.75 (2.033,154.993) < 0.001*
Leukemia/Solid tumor n (%) 6 (8.33)/10 (13.89) 6 (20)/11 (33.3) 4.577 (1.84, 51.383) < 0.001
Trauma n (%) 3 (4.17) 0 (0) 0.557 (0.547, 0.567) 0.553
Sepsis n (%) 65 (90.27) 25 (83.33) 0.538 (0.156, 1.855) 0.321
Peritonitis n (%) 8 (11.11) 8 (26.67) 2.909 (0.975, 8.68) 0.049
Cardiovascular disease n (%) 8 (11.11) 5 (16.67) 1.35 (0.401, 0.454) 0.627
Hepatic disorder n (%) 5 (6.94) 2 (6.67) 0.814 (0.149, 4.462) 0.813
Others n (%) 10 (13.89) 5 (16.67) 1.24 (0.385, 3.994) 0.718
WBC count(*109/L) M(Q1,Q3) 7.99 (5.81, 13.62) 5.1 (1.64, 14.78)   0.046
Neutropenia(*109/L) M(Q1,Q3) 4.88 (3.51, 9.1) 3.37 (0.61, 11.05)   0.158
CRP (mg/L) M(Q1,Q3) 37 (10, 74) 27 (16, 94.5)   0.406
PCT (ng/L) M(Q1,Q3) 0.48 (0.18, 5.08) 1.56 (0.53, 8.27)   0.066
Lactate (mmol/L)  mean ± SD 3.12 ± 2.9 3.09 ± 2.42   0.955
PRISM III  mean ± SD 6.73 ± 5.19 8.3 ± 4.76   0.183
Shock  n (%) 18, 25% 16, 53.33% 3.429 (1.403, 8.382) 0.006*
PaO2/FiO2  mean ± SD 269 ± 113.55 220.96 ± 150.16   0.139
Exposure factors      
Steroid n (%) 49 (68.06) 21 (70) 1.619 (0.662, 3.963) 0.289
Immune suppressor n (%) 11 (15.27) 8 (26.67) 2.017 (0.718, 5.665) 0.263
Length of hospital day (day,M(Q1,Q3)) 24 (14, 48.75) 31.5 (24.75, 41.5)   0.605
Length of PICU day (day,M(Q1,Q3)) 14 (8,23.5) 22.5 (13.25, 41)   0.459
Length of broad-spectrum antibiotic therapy (day,M(Q1,Q3)) 22 (12, 43) 31.5 (24.75, 41.5)   0.123
Length of mechanical ventilation (day, M(Q1,Q3)) 6 (1, 15) 10 (6, 25)   0.02
Length of CRRT/ECMO(h, M(Q1,Q3)) 0 (0, 0) 0 (0, 6)   0.02
Central vein catheter n (%) 69 (95.83) 30 (100) 1.435 (1.26, 1.634) 0.256
Arterial catheter
n (%)
58 (80.56) 29 (96.67) 7.0 (0.877, 55.872) 0.036
Intra trachea intubation n (%) 57 (79.17) 29 (96.67) 7.632 (0.96, 60.662) 0.027
Operation n (%) 31 (43.06) 20 (66.67) 2.645 (1.085, 6.448) 0.03
  1. *p < 0.01